Literature DB >> 3429676

Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.

T P Baglin1, A W Simpson, S M Price, B J Boughton.   

Abstract

High concentrations of circulating immune complexes were detected by polyethylene glycol precipitation in 11 of 20 patients with myelofibrosis secondary to chronic myeloproliferative disease. Circulating immune complexes showed a positive correlation with plasma IgG concentrations both in patients and controls. Covariance analysis of the two groups showed significantly increased polyethylene glycol precipitable IgG in patients when adjusted for plasma IgG concentrations, indicating that the patients had significantly increased concentrations of complexed IgG. The immune complexes contained IgG, C3, and fibronectin and were inversely correlated with plasma fibronectin concentrations, suggesting that this major non-specific opsonin is important for the normal clearance of immune complexes. Therapeutic plasmapheresis efficiently removed circulating complexes and produced an increase in plasma fibronectin. This suggests that plasmapheresis may be useful for controlling immune complex mediated complications of these disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429676      PMCID: PMC1141285          DOI: 10.1136/jcp.40.12.1468

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Immune complexes in myelofibrosis: a possible guide to management.

Authors:  C M Lewis; G D Pegrum
Journal:  Br J Haematol       Date:  1978-06       Impact factor: 6.998

2.  The in vivo and in vitro immunogenicity and antigenic specificity of lymphoid antigen fragment-oligoribonucleopeptide conjugates.

Authors:  L Yuan; D H Campbell
Journal:  Immunochemistry       Date:  1972-01

3.  Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.

Authors:  W D Creighton; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

5.  Fibronectin as an opsonic regulator of monocyte phagocytosis.

Authors:  A W Simpson; B J Boughton
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

6.  Plasma fibronectin in myeloproliferative disorders and chronic granulocytic leukaemia.

Authors:  D R Norfolk; M Bowen; B E Roberts; J A Child
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

7.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

8.  Immunologic abnormalities in myelofibrosis with activation of the complement system.

Authors:  B R Gordon; M Coleman; P Kohen; N K Day
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

9.  Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis.

Authors:  F C Cappio; R Vigliani; A Novarino; G Camussi; D Campana; F Gavosto
Journal:  Br J Haematol       Date:  1981-09       Impact factor: 6.998

10.  A study of the cellular and humoral immune response in patients with myelofibrosis.

Authors:  E Vellenga; N H Mulder; T H The; H O Nieweg
Journal:  Clin Lab Haematol       Date:  1982
  10 in total
  1 in total

1.  Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.

Authors:  T P Baglin; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.